NanoString Technologies Obtains $20,000,000 Series D Funding

  • Feed Type
  • Date
    11/7/2011
  • Company Name
    NanoString Technologies
  • Mailing Address
    530 Fairview Ave N Seattle, WA 98109
  • Company Description
    NanoString Technologies is developing a patent pending platform for single molecule identification and digital quantification. The NanoString system uniquely barcodes individual target molecules, scans them, and delivers a literal inventory of target molecules in the biological sample.
  • Website
    http://www.nanostring.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    The proceeds of the financing will be used to continue the growth of NanoString’s life science tools business, as well as advance the development of the company’s first molecular diagnostic product, a breast cancer assay based on the PAM50 gene expression signature.
  • M&A Terms
  • Venture Investor
    GE Healthare Financial Services
  • Venture Investor
    Individual Investor
  • Venture Investor
    Clarus Ventures
  • Venture Investor
    Draper Fisher Jurvetson
  • Venture Investor
    OVP Venture Partners

By posting a comment, you agree to our terms and conditions.